A Human Apolipoprotein E Mimetic Peptide Effectively Inhibits HSV-1 TK-Positive and TK-Negative Acute Epithelial Keratitis in Rabbits

被引:18
作者
Bhattacharjee, Partha S. [1 ,2 ]
Neumann, Donna M. [2 ]
Hill, James M. [3 ,4 ]
机构
[1] Xavier Univ, Dept Biol, New Orleans, LA 70125 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, Neurosci Ctr,Dept Microbiol Parasitol & Immunol, New Orleans, LA USA
[4] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA USA
关键词
apolipoprotein E; apolipoprotein E dimer peptide; epithelial keratitis; foscarnet; herpes simplex virus; trifluorothymidine; HERPES-SIMPLEX-VIRUS; STROMAL KERATITIS; EYE DISEASE; ACYCLOVIR; RESISTANT; TRIAL; MODEL;
D O I
10.1080/02713680802647662
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the antiviral effect of a peptide derived from human apolipoprotein E (1% apoEdp) with 1% trifluorothymidine against HSV-1 thymidine kinase (TK)-positive (HSV-1 McKrae) and with 3% foscarnet against HSV-1 TK-negative (KOS background) in the rabbit eye model of acute HSV-1 epithelial keratitis. Materials and Methods: Topical treatment began three days post-infection and continued for five days. Rabbits were treated 5 times per day with 1% apoEdp, 1% trifluorothymidine, 3% foscarnet, or PBS. Slit lamp examination was performed on a masked basis from post-infection days 3-10 to determine the severity of epithelial keratitis. Results: Topical treatment with 1% apoEdp was as effective as 1% trifluorothymidine against TK-positive and 3% foscarnet against TK-negative HSV-1 epithelial keratitis. Conclusions: ApoEdp 1% has efficacy for the topical treatment of TK-positive and TK-negative ocular herpes in the rabbit eye model. Thus, apoEdp has the potential to be used for treatment of keratitis caused by TK mutants.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 17 条
[1]   In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model [J].
Anand, BS ;
Hill, JM ;
Dey, S ;
Maruyama, K ;
Bhattacharjee, PS ;
Myles, ME ;
Nashed, YE ;
Mitra, AK .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (06) :2529-2534
[2]  
BEHRENSBAUMANN W, 1992, ACTA OPHTHALMOL, V70, P690
[3]   Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model [J].
Bhattacharjee, Partha S. ;
Neumann, Donna M. ;
Foster, Timothy P. ;
Clement, Christian ;
Singh, Gyanendra ;
Thompson, Hilary W. ;
Kaufman, Herbert E. ;
Hill, James M. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (10) :4263-4268
[4]  
Coen Donald M., 1994, Trends in Microbiology, V2, P481, DOI 10.1016/0966-842X(94)90652-1
[5]   The receptor-binding region of human apolipoprotein E has direct anti-infective activity [J].
Dobson, CB ;
Sales, SD ;
Hoggard, P ;
Wozniak, MA ;
Crutcher, KA .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (03) :442-450
[6]   Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase [J].
Griffiths, Anthony ;
Link, Malen A. ;
Furness, Caroline L. ;
Coen, Donald M. .
JOURNAL OF VIROLOGY, 2006, 80 (13) :6568-6574
[7]   Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus - An epidemiologic study [J].
Hodge, WG ;
Margolis, TP .
OPHTHALMOLOGY, 1997, 104 (01) :120-124
[8]   AN INVITRO STUDY OF OPHTHALMIC ANTIVIRAL AGENT TOXICITY ON RABBIT CORNEAL EPITHELIUM [J].
IMPERIA, PS ;
LAZARUS, HM ;
DUNKEL, EC ;
PAVANLANGSTON, D ;
GEARY, PA ;
LASS, JH .
ANTIVIRAL RESEARCH, 1988, 9 (04) :263-272
[9]   Herpetic eye disease in diabetic patients [J].
Kaiserman, I ;
Kaiserman, N ;
Nakar, S ;
Vinker, S .
OPHTHALMOLOGY, 2005, 112 (12) :2184-2188
[10]   THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2]-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS [J].
KAUFMAN, HE ;
HEIDELBERGER, C .
SCIENCE, 1964, 145 (363) :585-&